Theravance Biopharma, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Theravance Biopharma, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Tops Q2 EPS by 21c

August 3, 2021 4:01 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($0.80), $0.21 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $15.41 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

... More